Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The study suggests using a score of 11 on the mFG scale to diagnose hirsutism in Turkish women, with adjustments for age, skin type, and family history.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Ginsenoside Rb1 may help remodel hypertrophic scars effectively at a dose of 0.56 mg.

ICD codes for skin conditions vary in accuracy, needing better validation for some common conditions.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

The updated criteria improve the accuracy of diagnosing lupus.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

The rs1128977 gene variant may affect cholesterol and body measurements.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Dermoscopy effectively assesses and improves acne scar treatments.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

The PRECISE scale helps estimate how many grafts are needed for hair transplant based on the severity of hair loss.

Long COVID symptoms are common and the new method will help test if remdesivir reduces them.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

International medical graduates scored higher than U.S. graduates on a medical exam.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

LSCI-HR is reliable for monitoring blood flow in wound healing in mice.

The new criteria for classifying lupus are more accurate and comprehensive.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

A new tool can predict hair regrowth in patchy alopecia areata patients.

Carcinosin, a homeopathic remedy, helped a young girl with alopecia areata regrow hair and reduce psychological symptoms.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.